Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS Negl Trop Dis ; 14(7): e0008488, 2020 07.
Article in English | MEDLINE | ID: mdl-32716931

ABSTRACT

BACKGROUND: Visceral leishmaniasis (VL) is a major neglected disease, potentially fatal, whose control is still impaired by inefficient and/or expensive treatment and diagnostic methods. The most promising approach for VL diagnosis uses serological assays with recombinant proteins, since they are more efficient and easier to perform. Tests developed for the human form of the disease, however, have not been shown to be efficient for its diagnosis in the canine host, the major reservoir for the American VL. METHODOLOGY/PRINCIPAL FINDINGS: Here, we describe a systematic approach aimed at the production of a new chimeric protein potentially able to be used for both human and canine VL diagnosis and based both on in silico gene design and experimental data. Starting from the previous identification of Leishmania infantum recombinant antigens efficient for the diagnosis of either human or canine VL, three of the best performing antigens were selected (Lci2, Lci3 and Lci12). After a preliminary evaluation validating the chimeric approach, DNA fragments encoding predicted antigenic regions from each protein, enriched with repeats, were joined in various combinations to generate a total of seventeen chimeric genes optimized for prokaryotic expression. These were assessed for optimal expression and purification yield, with four chimeric proteins being efficiently produced. Their diagnostic potential was then evaluated through ELISA assays with sera from VL afflicted humans and dogs. After two rounds of gene design, the results showed high levels of sensitivity for the best chimeric protein, named Q5, in humans (82%) and dogs (100%) with 100% specificity in comparison with healthy controls. A single non-specific reaction was seen with serum from individuals with tegumentary leishmaniasis. CONCLUSION: The newly described chimeric protein is potentially useful for the detection of both humans and dogs afflicted with VL, with its use in rapid tests necessary for validation as a new diagnostic tool.


Subject(s)
Dog Diseases/diagnosis , Leishmaniasis, Visceral/veterinary , Serologic Tests/veterinary , Amino Acid Sequence , Animals , Antigens, Protozoan/chemistry , Dog Diseases/blood , Dogs , Escherichia coli/metabolism , Gene Expression Regulation , Humans , Leishmaniasis, Visceral/blood , Leishmaniasis, Visceral/diagnosis , Protozoan Proteins/chemistry , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism , Sensitivity and Specificity , Serologic Tests/methods , Transcriptome
2.
PLoS One ; 12(9): e0184867, 2017.
Article in English | MEDLINE | ID: mdl-28957332

ABSTRACT

Current strategies for the control of zoonotic visceral leishmaniasis (VL) rely on its efficient diagnosis in both human and canine hosts. The most promising and cost effective approach is based on serologic assays with recombinant proteins. However, no single antigen has been found so far which can be effectively used to detect the disease in both dogs and humans. In previous works, we identified Leishmania infantum antigens with potential for the serodiagnosis of VL. Here, we aimed to expand the panel of the available antigens for VL diagnosis through another screening of a genomic expression library. Seven different protein-coding gene fragments were identified, five of which encoding proteins which have not been previously studied in Leishmania and rich in repetitive motifs. Poly-histidine tagged polypeptides were generated from six genes and evaluated for their potential for diagnosis of VL by ELISA (Enzyme Linked ImmunoSorbent Assay) with sera from infected humans and dogs. None of those was valid for the detection of human VL (26-52% sensitivity) although their performance was increased in the canine sera (48-91% sensitivity), with one polypeptide useful for the diagnosis of canine leishmaniasis. Next, we assayed a mixture of three antigens, found to be best for human or canine VL, among 13 identified through different screenings. This "Mix" resulted in similar levels of sensitivity for both human (84%) and canine (88%) sera. With improvements, this validates the use of multiple proteins, including antigens identified here, as components of a single system for the diagnosis of both forms of leishmaniasis.


Subject(s)
Antigens, Protozoan/immunology , Leishmaniasis, Visceral/diagnosis , Leishmaniasis, Visceral/veterinary , Recombinant Proteins/immunology , Serologic Tests/methods , Amino Acid Sequence , Animals , Antigens, Protozoan/chemistry , Dogs , Electrophoresis, Polyacrylamide Gel , Enzyme-Linked Immunosorbent Assay , Humans , Leishmania infantum/immunology , Leishmaniasis, Visceral/blood , Peptides/metabolism , Sequence Analysis, Protein
3.
Am J Trop Med Hyg ; 85(6): 1025-34, 2011 Dec.
Article in English | MEDLINE | ID: mdl-22144438

ABSTRACT

To expand the available panel of recombinant proteins that can be useful for identifying Leishmania-infected dogs and for diagnosing human visceral leishmaniasis (VL), we selected recombinant antigens from L. infantum, cDNA, and genomic libraries by using pools of serum samples from infected dogs and humans. The selected DNA fragments encoded homologs of a cytoplasmic heat-shock protein 70, a kinesin, a polyubiquitin, and two novel hypothetical proteins. Histidine-tagged recombinant proteins were produced after subcloning these DNA fragments and evaluated by using an enzyme-linked immunosorbent assays with panels of canine and human serum samples. The enzyme-linked immunosorbent assays with different recombinant proteins had different sensitivities (67.4-93.0% and 36.4-97.2%) and specificities (76.1-100% and 90.4-97.3%) when tested with serum samples from Leishmania-infected dogs and human patients with VL. Overall, no single recombinant antigen was sufficient to serodiagnosis all canine or human VL cases.


Subject(s)
Dog Diseases/diagnosis , Genes, Protozoan/genetics , Leishmania infantum/genetics , Leishmaniasis, Visceral/diagnosis , Animals , Antigens, Protozoan/genetics , Cloning, Molecular , Dog Diseases/parasitology , Dogs , Enzyme-Linked Immunosorbent Assay/methods , Enzyme-Linked Immunosorbent Assay/veterinary , HSP70 Heat-Shock Proteins/genetics , Humans , Kinesins/genetics , Leishmaniasis, Visceral/parasitology , Leishmaniasis, Visceral/veterinary , Polyubiquitin/genetics , Recombinant Proteins/genetics , Sensitivity and Specificity , Serologic Tests/methods , Serologic Tests/veterinary
SELECTION OF CITATIONS
SEARCH DETAIL
...